- Home
- PROF vs INBX Comparison
PROF vs INBX Comparison
Compare PROF & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROF
- INBX
- Stock Information
- Founded
- PROF N/A
- INBX 2010
- Country
- PROF Canada
- INBX United States
- Employees
- PROF N/A
- INBX N/A
- Industry
- PROF Medical/Dental Instruments
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- PROF Health Care
- INBX Health Care
- Exchange
- PROF Nasdaq
- INBX Nasdaq
- Market Cap
- PROF 201.2M
- INBX 198.2M
- IPO Year
- PROF N/A
- INBX 2020
- Fundamental
- Price
- PROF $5.85
- INBX $14.05
- Analyst Decision
- PROF Strong Buy
- INBX Hold
- Analyst Count
- PROF 1
- INBX 1
- Target Price
- PROF $12.00
- INBX N/A
- AVG Volume (30 Days)
- PROF 65.7K
- INBX 100.7K
- Earning Date
- PROF 03-06-2025
- INBX 05-08-2025
- Dividend Yield
- PROF N/A
- INBX 6.06%
- EPS Growth
- PROF N/A
- INBX N/A
- EPS
- PROF N/A
- INBX 112.62
- Revenue
- PROF $10,680,000.00
- INBX $200,000.00
- Revenue This Year
- PROF $165.23
- INBX N/A
- Revenue Next Year
- PROF $96.94
- INBX N/A
- P/E Ratio
- PROF N/A
- INBX $0.12
- Revenue Growth
- PROF 48.35
- INBX N/A
- 52 Week Low
- PROF $4.75
- INBX $10.80
- 52 Week High
- PROF $11.42
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- PROF 29.08
- INBX 52.88
- Support Level
- PROF $4.75
- INBX $13.51
- Resistance Level
- PROF $7.15
- INBX $14.64
- Average True Range (ATR)
- PROF 0.47
- INBX 0.74
- MACD
- PROF -0.12
- INBX -0.03
- Stochastic Oscillator
- PROF 43.14
- INBX 45.85
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.